Out-licensing
Up-to-date access to technology licensing opportunities worldwide.
- Out-licensing
- Browse
Licensing opportunities
Proprietary supercritical fluid (SCF) technology to improve bioavailability, enhance stability and optimise drug delivery for small and large molecules in a range of dosage forms More
Methods, systems and transgenic animals useful for screening, diagnosing and treating FUS1 related disorders More
Enhancing the dissolution performance of small and large molecules in a range of dosage forms More
Increasing the stability and improving the reconstitution of biomolecules using supercritical fluid (SCF) processing More
Related Reports
Market Research Reports provided by reports.innovaro.com
May 2011 - 15 pages - $250
May 2011 - 86 pages - $2,000
Jul 2011 - 49 pages - $5,700
Jun 2010 - 69 pages - $2,000
Oct 2011 - 96 pages - $3,500
Mar 2006 - 200 pages - $3,500
Jan 2011 - 18 pages - $500
Dec 2010 - 51 pages - $500
Dec 2010 - 52 pages - $500
Jul 2011 - 63 pages - $500
Your selection
Browse By
- Industry sector
- Animal health
- Biotechnology
- Diagnostic
- Drug delivery
- Drug discovery
- Medical device
- Pharmaceutical
- Research tools
- Development phase
- Early Stage
- Preclinical
- Phase I
- Phase I/II
- Phase II
- Phase III
- Phase III/IV
- Preregistration
- Registered
© Copyright 1998-2012 Innovaro Europe Ltd 
All rights reserved. Terms and Conditions | Contact us